COVID-19 PLACID trial: ICMR approves 21 institutions for participating in Coronavirus plasma therapy trials - (The Financial Express via NewsPoints Desk)

  • The Indian Council of Medical Research (ICMR) has approved 21 institutions for participating in a randomised controlled study to assess the safety and efficacy of convalescent plasma to limit complications associated with COVID-19, reported The Financial Express.

  • The sample size of the study is 452, and once 400 patients are enrolled, no more sites will be added.

  • "We have received an overwhelming response. Expression of interest was received from 111 institutions. As of May 4, the ICMR has approved 21 institutions in the [Phase II] PLACID trial," an official said.

To read more NewsPoints articles, click here.